We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

2018:HKEXAAC Technologies Holdings Inc. Analysis

Data as of 2026-03-14 - not real-time

HK$32.28

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

AAC Technologies is trading at HK$32.28, well below its 20‑day SMA of 35.32 and the 200‑day SMA of 40.01, indicating a bearish price trajectory but also a clear technical discount. The RSI sits at 33.2, suggesting oversold conditions, while the MACD histogram remains negative, confirming bearish momentum. Despite this, the stock’s DCF‑derived fair value of HK$72.16 implies an upside of over 80%, and the analyst consensus targets a median price of HK$59.81. Revenue growth of 18.4% YoY, a gross margin of 21.7% and a free cash flow conversion of roughly 60% underscore robust operating fundamentals. The dividend payout ratio is a modest 12% with a yield of 0.74%, supporting sustainability.
The company’s beta of 0.31 points to low market‑wide volatility, yet the 30‑day price volatility is high at 39.8%, reflecting short‑term price swings. Low leverage (debt‑to‑equity 46.8%) and solid cash balances further cushion downside risk. Given the substantial valuation gap, strong cash generation, and modest dividend, the investment case leans toward a buy stance across horizons, while remaining mindful of sector‑specific regulatory and geographic exposures.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Oversold technical indicators (RSI ~33, price below SMA20/50)
  • Proximity to support level at HK$31.36
  • Increasing volume suggesting accumulation

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • DCF upside of ~81% and analyst median target near HK$60
  • Strong revenue growth (18.4%) and cash flow generation
  • Sustainable dividend with low payout ratio

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Strategic positioning in high‑growth tech and automotive segments
  • Balanced capital structure and ample liquidity
  • Long‑term earnings visibility from diversified product portfolio

Key Metrics & Analysis

Financial Health

Revenue Growth18.40%
Profit Margin7.27%
P/E Ratio15.4
ROE9.13%
ROA3.00%
Debt/Equity46.81
P/B Ratio1.4
Op. Cash FlowHK$5.4B
Free Cash FlowHK$3.0B
Industry P/E33.7

Technical Analysis

TrendBearish
RSI33.2
SupportHK$31.36
ResistanceHK$38.88
MA 20HK$35.32
MA 50HK$37.05
MA 200HK$40.01
MACDBearish
VolumeIncreasing
Fear & Greed Index72.88

Valuation

Fair ValueHK$72.16
Target PriceHK$58.52
Upside/Downside81.30%
GradeUndervalued
TypeGrowth
Dividend Yield0.74%

Risk Assessment

Beta0.31
Volatility39.77%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.